Physician
Abrakidabra Pediatric Clinic, LLC
Abrakidabra Pediatric Clinic, LLC was paid $3.34M by Medicaid between Jan 2019 and Nov 2024, across 66 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoABRAKIDABRA PEDIATRIC CLINIC, LLC
SPRING HILL, FL 34606
SPRING HILL, FL 34606
33aNPI1366699944assigned 08/26/2008
33bProvider typePediatrics Physician
28Total paid$3.34M
24GClaims147,379
24DCodes billed66
24AFirst – last monthJan 2019 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#93 of 971
Median peer was paid$238K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 11,932 | $372K | |
| 2020 | 14,781 | $444K | |
| 2021 | 23,378 | $556K | |
| 2022 | 33,114 | $1.04M | |
| 2023 | 37,206 | $764K | |
| 2024incomplete | 26,968 | $171K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 16,960 | 12,836 | $1.19M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 15,635 | 11,382 | $753K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.4% | 2,515 | 2,332 | $212K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5.9% | 3,144 | 2,538 | $198K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.1% | 1,968 | 1,819 | $171K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.7% | 1,426 | 1,350 | $122K |
| 97802 | 2.9% | 6,415 | 5,712 | $98K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.8% | 4,600 | 4,228 | $92K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 1,222 | 1,154 | $72K |
| A4927 | Gloves, non-sterile, per 100 | 1.8% | 10,300 | 7,820 | $59K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 541 | 510 | $58K |
| 99441 | 1.5% | 7,710 | 5,485 | $50K |
54 more codes
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.3% | 384 | $43K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.2% | 514 | $41K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 4,792 | $36K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 4,952 | $26K |
| 99442 | <1% | 1,951 | $20K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,114 | $20K |
| 99401 | <1% | 871 | $16K | |
| 94760 | <1% | 11,548 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,525 | $12K |
| 81002 | <1% | 6,167 | $9K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 265 | $5K |
| 99050 | <1% | 589 | $4K | |
| 81025 | <1% | 769 | $3K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 511 | $3K |
| 99188 | <1% | 128 | $2K | |
| 99354 | <1% | 19 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 38 | $2K |
| 99000 | <1% | 10,145 | $2K | |
| 86328 | <1% | 82 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 184 | $1K |
| 99381 | <1% | 16 | $1K | |
| 99383 | <1% | 12 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 573 | $1K |
| 3725F | <1% | 537 | $875.29 | |
| 99173 | <1% | 5,442 | $865.12 | |
| 87110 | <1% | 143 | $788.92 | |
| 92567 | <1% | 115 | $474.54 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 64 | $334.68 |
| A4930 | Gloves, sterile, per pair | <1% | 140 | $243.48 |
| 90734 | <1% | 397 | $225.15 | |
| 99051 | <1% | 64 | $196.82 | |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 353 | $119.49 |
| 69210 | <1% | 17 | $96.03 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 159 | $47.15 |
| 90620 | <1% | 107 | $26.10 | |
| 87070 | <1% | 21 | $21.39 | |
| 99070 | <1% | 7,729 | $10.00 | |
| 90651 | 0% | 843 | $0.00 | |
| 90716 | 0% | 72 | $0.00 | |
| 90723 | 0% | 14 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 354 | $0.00 |
| 90686 | 0% | 1,183 | $0.00 | |
| 90696 | 0% | 13 | $0.00 | |
| 99412 | 0% | 38 | $0.00 | |
| 90674 | 0% | 15 | $0.00 | |
| 99072 | 0% | 42 | $0.00 | |
| 90633 | 0% | 454 | $0.00 | |
| 90648 | 0% | 110 | $0.00 | |
| 99080 | 0% | 353 | $0.00 | |
| A4928 | Surgical mask, per 20 | 0% | 6,371 | $0.00 |
| 90670 | 0% | 189 | $0.00 | |
| 90707 | 0% | 87 | $0.00 | |
| 90715 | 0% | 178 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 190 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIDDLE, HEATHER (PRESIDENT)